ProCE Banner Activity

CME

Think Tank on Melanoma: Optimizing Therapy for Patients in an Evolving Treatment Landscape

Text Module

Evan Lipson, MD, offers expert insight on the optimization of therapy for patients with melanoma in this text-based activity with accompanying slides.

Physicians: Maximum of 1.00 AMA PRA Category 1 Credit

Released: August 02, 2023

Expiration: August 01, 2024

Share

Faculty

Evan J. Lipson

Evan J. Lipson, MD

Associate Professor of Oncology
Melanoma and Cancer Immunology Programs
Bloomberg-Kimmel Institute for Cancer Immunotherapy
Johns Hopkins University School of Medicine
Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

Target Audience

This program is intended for physicians and other healthcare professionals who care for patients with melanoma.

Program Learning Goal

The goal of this activity is to improve the knowledge, competence, and performance of HCPs treating patients with melanoma.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the mechanism of action for novel and emerging agents and combinations for treating patients with melanoma 

  • Integrate emerging data on therapeutic sequencing options into the context of treatment for patients with metastatic melanoma

  • Apply the efficacy and safety evidence of BRAF/MEK inhibition, checkpoint inhibition, and combination therapy strategies to optimally manage melanoma in the adjuvant setting

  • Develop proactive management strategies for AEs associated with targeted and immunotherapeutic approaches used to treat melanoma 

  • Evaluate emerging data on novel investigational targeted and immunotherapeutic approaches to identify patients with melanoma who may be eligible for participation in a clinical trial

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Evan J. Lipson, MD

Associate Professor of Oncology
Melanoma and Cancer Immunology Programs
Bloomberg-Kimmel Institute for Cancer Immunotherapy
Johns Hopkins University School of Medicine
Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland

Evan J. Lipson, MD: consultant/advisor/speaker: Bristol-Myers Squibb, CareDX, Eisai, Genentech, HUYA Bioscience International, Immunocore, Instil Bio, Merck, Natera, Nektar, Novartis, Oncosec, Pfizer, Rain Therapeutics, Regeneron, Replimune, Sanofi-Aventiz; researcher (paid to institution): Bristol-Myers Squibb, Haystack, Merck, Regeneron, Sanofi.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, learners must follow these steps during the period from August 02, 2023, through August 01, 2024:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

The program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.